XML 151 R6.htm IDEA: XBRL DOCUMENT v3.20.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Operating:    
Net earnings (loss) $ 717.1 $ (25.6)
Adjustments to reconcile net earnings (loss) to net cash provided from operating activities:    
Depreciation, depletion and amortization 731.3 772.4
Gain on disposition of associate and other interests - net   (2.1)
Reversals of impairment charges (361.8)  
Equity in (earnings) losses of joint ventures - net (0.1) 0.3
Share-based compensation expense 14.3 14.6
Finance expense 107.9 101.2
Deferred tax expense 41.1 8.9
Foreign exchange (gains) losses and other (53.1) 12.5
Reclamation recovery (11.9) (8.0)
Changes in operating assets and liabilities:    
Accounts receivable and other assets (64.5) (22.7)
Inventories 53.8 (5.7)
Accounts payable and accrued liabilities 165.9 69.8
Cash flow provided from (used in) operating activities 1,340.0 915.6
Income taxes recovered (paid) (115.1) (126.9)
Net cash flow provided from operating activities 1,224.9 788.7
Investing:    
Additions to property, plant and equipment (1,105.2) (1,043.4)
Acquisitions (30.0) (304.2)
Net proceeds from the sale of (additions to) long-term investments and other assets 71.6 (52.9)
Net proceeds from the sale of property, plant and equipment 31.9 6.4
Increase in restricted cash (2.5) (0.6)
Interest received and other - net 7.6 7.7
Net cash flow used in investing activities (1,026.6) (1,387.0)
Financing:    
Proceeds from drawdown of debt 300.0 80.0
Repayment of debt (200.0) (80.0)
Payment of lease liabilities (14.3)  
Interest paid (55.6) (57.9)
Dividends paid to non-controlling interest (5.0) (13.0)
Other - net   (1.7)
Net cash flow provided from (used in) financing activities 25.1 (72.6)
Effect of exchange rate changes on cash and cash equivalents 2.7 (5.9)
Increase (decrease) in cash and cash equivalents 226.1 (676.8)
Cash and cash equivalents, beginning of period 349.0 1,025.8
Cash and cash equivalents, end of period $ 575.1 $ 349.0